Neuphoria Therapeutics (NEUP) Share-based Compensation (2023 - 2026)
Neuphoria Therapeutics (NEUP) reported Share-based Compensation of $76,336 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 22.3% from $98,267 a year earlier but up 8.6% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Share-based Compensation (2023 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Neuphoria Therapeutics posted Share-based Compensation of $351,600, up 114.7% from FY2025.
- Share-based Compensation has a three-year compound annual growth rate of -36.1% (FY2023 to FY2026).
- By fiscal year, Share-based Compensation came in at $163,772 in FY2025 (-79.9%), $814,808 in FY2024 (-39.4%) and $1.35 million in FY2023.
- Five-year quarterly Share-based Compensation spans a low of $17,375 in fiscal Q3 2024 and a high of $556,978 in fiscal Q2 2024.
- Year over year, Share-based Compensation gained in four of the last eight quarters, with growth averaging 100.4%.
- The high point for year-over-year Share-based Compensation in five years was fiscal Q2 2026 (growth of 424.0%); the low point was fiscal Q2 2025 (a decline of 96.6%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $70,286 (Q3 2026), $100,000 (Q2 2026) and $111,277 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - | 76,336.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 76,336.00 |
| Mar 31, 2026 | 70,286.00 |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 111,277.00 |
| Jun 30, 2025 | 98,267.00 |
| Mar 31, 2025 | 19,685.00 |
| Dec 31, 2024 | 19,084.00 |
| Sep 30, 2024 | 26,736.00 |
| Jun 30, 2024 | 107,716.00 |
| Mar 31, 2024 | 17,375.00 |
| Dec 31, 2023 | 556,978.00 |
| Sep 30, 2023 | 132,739.00 |
API Access
Neuphoria Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();